Privia Health Group (PRVA) concentration risks

The company's only disclosed concentration is geographic in character. Operations of the company and its Medical Groups are concentrated in certain U.S. states — a moderate-share structural exposure by disclosed size. The filing does not name the specific states or provide a percentage breakdown, making the exposure qualitative rather than precisely quantifiable from the disclosed data. Nevertheless, the structural character is clear: the company's physician platform and care delivery infrastructure are geographically fixed, and expansion into new states requires regulatory approvals, provider recruitment, and payer contracting that take time to establish. The practical effect is that the company's revenue trajectory and growth potential are partially dependent on market conditions, payer mix, and regulatory environments in the states where it currently operates. An adverse shift in reimbursement rates, state-specific Medicaid or commercial insurance dynamics, or competitive entry in those key geographies would affect results without an immediately available offset from states where the company is not yet present. Conversely, the concentration also reflects where the company has built scale and operational density, which tends to support margins and physician retention. On balance, this is a moderate-share geographic concentration typical for a physician enablement and value-based care company at a growth stage. The profile is narrow — a single disclosed concentration type — and its structural nature means it is known and planned for rather than representing an unexpected dependency. There are no disclosed customer, product, or counterparty concentrations alongside it.

For the engine’s reasoning on PRVA’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.